4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To prospectively analyse the risk for disease relapses in patients with rheumatoid arthritis (RA) in sustained remission, either continuing, tapering or stopping disease-modifying antirheumatic drugs (DMARDs) in a prospective randomised controlled trial.

          Related collections

          Author and article information

          Journal
          Ann. Rheum. Dis.
          Annals of the rheumatic diseases
          BMJ
          1468-2060
          0003-4967
          Jan 2016
          : 75
          : 1
          Affiliations
          [1 ] Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany Department of Internal Medicine 2, The Vinforce Study Group, Saint Vincent Hospital, Vienna, Austria.
          [2 ] Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany.
          [3 ] Department of Internal Medicine 2, University of Wurzburg, Wurzburg, Germany.
          [4 ] Department of Internal Medicine 2, University of Wurzburg, Wurzburg, Germany Rheumatology Practice, Erlangen, Germany.
          [5 ] Department of Internal Medicine 2, University of Wurzburg, Wurzburg, Germany Rheumatology Practice and Department of Internal Medicine 2, Clinic Burghausen, Burghausen, Germany.
          [6 ] Department of Rheumatology and Clinical Immunology, Asklepios Medical Center, Bad Abbach, Germany.
          [7 ] Rheumatology Practice, Bamberg, Germany.
          [8 ] Rheumatology Practice, Bayreuth, Germany.
          [9 ] Rheumatology Practice, Erlangen, Germany.
          [10 ] Department of Internal Medicine V, Division of Rheumatology, University of Heidelberg, Heidelberg, Germany ACURA Center for Rheumatic Diseases, Baden-Baden, Germany.
          [11 ] Rheumatology Practice, Nuremberg, Germany.
          [12 ] Schlosspark Clinic, Berlin, Germany.
          [13 ] Rheumatology Practice, Hildesheim, Germany.
          [14 ] Department of Internal Medicine 2, University of Tubingen, Tubingen, Germany.
          Article
          annrheumdis-2014-206439
          10.1136/annrheumdis-2014-206439
          25660991
          87e4c7d5-b294-45b5-8a43-7a466b6362f3
          History

          DMARDs (biologic),DMARDs (synthetic),Disease Activity,Rheumatoid Arthritis,Treatment

          Comments

          Comment on this article